11/21
08:20 am
bmra
Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis [Yahoo! Finance]
Medium
Report
Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis [Yahoo! Finance]
11/21
08:19 am
bmra
Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis
Medium
Report
Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis
11/7
09:17 am
bmra
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements [Yahoo! Finance]
Low
Report
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements [Yahoo! Finance]
11/7
09:09 am
bmra
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements
Low
Report
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements
10/30
08:22 am
bmra
Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain [Yahoo! Finance]
High
Report
Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain [Yahoo! Finance]
10/30
08:19 am
bmra
Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain
High
Report
Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain
10/16
10:42 am
bmra
Biomerica reports Q1 results [Seeking Alpha]
Low
Report
Biomerica reports Q1 results [Seeking Alpha]
10/16
09:00 am
bmra
Biomerica Reports First Quarter Fiscal 2025 Financial Results
Medium
Report
Biomerica Reports First Quarter Fiscal 2025 Financial Results